This variant is an eQTL for increased expression of MSH6 in many tissues, including nerve, is associated with increased expression of MSH6 in patients with LGG (p = 0.00732), and has previously been reported to be associated with a decreased risk of prostate cancer [57, 58]. This evidence concerns the gene MSH6 and Familial prostate cancer.